DSIP: Research Chemistry and Literature
DSIP is a nonapeptide. The sequence runs Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, or WAGGDASGE in single-letter code, and the acronym expands to Delta Sleep-Inducing Peptide. The neutral molecule has the formula C35H48N10O15 and an average mass close to 849 daltons, the figure quoted throughout the older literature. Six of the nine residues are glycine, alanine or serine. What remains is one tryptophan and two acidic side chains, so the chain is small, flexible, strongly hydrophilic and carries no basic residue at all.
None of this was designed. The peptide was isolated from the cerebral venous blood of rabbits by the Basel group of Monnier and Schoenenberger during the 1970s, and the characterisation was published in 1977. The name records the electroencephalographic observation that prompted the isolation, nothing more. Delta refers to the low-frequency band of the rabbit electroencephalogram the Basel laboratory was measuring when it went looking for a chemical correlate.
Reference data
- CAS number
- 62568-57-4
- Chemical formula
- C₃₅H₄₈N₁₀O₁₅
- Molar mass
- 848.81 g/mol
- Shelf life
- 24 months
Origin and identification
The Basel programme started from an electrophysiological observation rather than a chemical one. Monnier and colleagues stimulated the intralaminar thalamic region of donor rabbits, collected cerebral venous blood by extracorporeal dialysis, and fractionated the dialysate. Activity in the recipient electroencephalogram tracked one fraction. Isolating what was in it took most of a decade.
Schoenenberger and Monnier reported the characterisation in the Proceedings of the National Academy of Sciences in 1977. Amino acid analysis, sequence determination and synthesis followed the next year in Pflugers Archiv, as the eleventh paper in the series. That second paper also settled a stereochemical point: only the alpha-aspartyl configuration at position five was active in their assay, and the beta-aspartyl isomer was not.
Independent total synthesis came later. Ji and co-workers published a classical solution-phase route in 1983 and confirmed their material was free of alpha to beta transposition at the aspartyl residue, which had been the principal synthetic hazard in the sequence and remains the reason the position is worth checking.
Preclinical research context
The primary literature is electroencephalographic. Rabbits were the original recording species, and the measured quantity was spectral power in the delta band together with spindle density, extracted by computer-assisted analysis under double-blind conditions. The 1977 characterisation compared the intact nonapeptide against eight related compounds, among them metabolic fragments and structural variants, across a cohort of fifty-eight animals. Only the complete sequence produced the reported spectral shift, which is what fixed attention on the full nine residues.
Comparative work later extended recording to rats, mice and cats. Graf and Kastin summarised the position in a 1984 review and noted that the delta-band observation in rabbits and rodents did not transfer cleanly to cats, where rapid-eye-movement measures moved instead. They also described a response curve that was not monotonic. Species dependence and non-monotonic behaviour are recurring features of this body of work and account for a good deal of the disagreement between laboratories.
Schoenenberger catalogued the wider set of reported observations the same year: circadian locomotor rhythm in rodents, brain transmitter levels, plasma protein and cortisol profiles, and detection of DSIP-like immunoreactive material in brain tissue, peripheral organs and plasma across several mammalian species. No endogenous receptor has been definitively assigned. The nonapeptide remains an orphan in the strict sense, and papers separated by decades rarely share assay conditions closely enough for direct comparison.
Analytical characterisation
Reverse-phase HPLC on C18 with an acetonitrile gradient in dilute trifluoroacetic acid provides the purity figure. DSIP is acidic and hydrophilic and elutes early, so separation from truncated and deamidated species is won in the first part of the gradient rather than at the end, and a steep method will bury the impurities under the main band. The tryptophan at position one does give a usable 280 nanometre signal, which is convenient for peak tracking, though the quantitative purity number is still read at 214 nanometres where every amide bond contributes.
Mass spectrometry supplies identity. Electrospray ionisation against a monoisotopic neutral mass of 848.33 gives a singly protonated ion near m/z 849.3, and the two carboxylate side chains make negative mode viable as a cross-check. Tandem fragmentation is worth running rather than trusting intact mass alone, for a specific reason: the aspartyl isomerisation the Basel group flagged in 1978 does not change the mass by a single unit.
Alpine sources lot-specific Certificates of Analysis from Janoshik Analytical, an independent laboratory, and each certificate carries the chromatogram and the mass spectrum for that lot. Read the retention window and the integration table, not only the headline percentage. A certificate belongs to the batch it was cut from.
Handling and storage
The lyophilised powder tolerates ambient conditions in transit. Shipping dry peptide without a cold chain is ordinary practice and does not compromise a lot that arrives sealed and intact. Storage on receipt is minus 20 degrees Celsius, in the dark. Light protection has a specific justification here rather than a generic one, because the tryptophan at position one is photolabile and will oxidise given the opportunity.
Once reconstituted, hold the solution at 2 to 8 degrees Celsius and treat its working life as short. Aspartyl-containing sequences are prone to isomerisation and succinimide formation in aqueous buffer, the rate is pH sensitive, and an unbuffered stock left on the bench is a poor idea even over a few hours.
Divide the stock into single-use aliquots before anything goes into the freezer. Freeze-thaw cycling is cumulative and, unless someone writes it down, invisible, which makes it the failure mode most often blamed on the peptide rather than on the handling. Label each aliquot with the lot number and the date the vial was first opened.
References
- Characterization of a delta-electroencephalogram (-sleep)-inducing peptide
- The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptide
- Synthesis of delta sleep-inducing peptide (DSIP) and its physiological activity
- Delta-sleep-inducing peptide (DSIP): a review
- Characterization, properties and multivariate functions of delta-sleep-inducing peptide (DSIP)
- Delta Sleep-Inducing Peptide, CID 68816
Related compounds
This page summarises published laboratory research for reference purposes. Materials described are supplied for in vitro and analytical research use only. Not for human or veterinary consumption.